Fate Therapeutics FATE
NASDAQ FATE
$2.37 -0.01 (-0.42%)
At close: Sep 30, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Shares Outstanding (Entity) (2012 - 2026)

Updated

Fate Therapeutics (FATE) posted Shares Outstanding (Entity) of 116.69 million for Q2 2026, up 1.8% from 114.66 million a year earlier and up 0.4% from the prior quarter.

Analysis

Fate Therapeutics (FATE) Shares Outstanding (Entity) (2012 - 2026) Analysis & Trends

For FY2025, Fate Therapeutics' Shares Outstanding (Entity) came in at 115.36 million, up 1.3% from FY2024.

  • Annual Shares Outstanding (Entity) has increased for 14 consecutive years, with a five-year compound annual growth rate of 5.6% (FY2020 to FY2025).
  • In prior years, Fate Therapeutics' Shares Outstanding (Entity) was 113.93 million in FY2024 (+15.5%), 98.63 million in FY2023 (+1.4%), 97.29 million in FY2022 (+1.6%) and 95.73 million in FY2021 (+9.1%).
  • The Q2 2026 figure stands as the highest quarterly Shares Outstanding (Entity) in data going back to Q3 2012.
  • On a year-over-year basis, Shares Outstanding (Entity) has increased in each of the last 47 quarters, with growth averaging 4.8% over the last eight quarters.
  • The year-over-year growth in Shares Outstanding (Entity) has ranged between 0.7% (Q1 2025) and 15.9% (Q1 2024) over the last five years.
  • According to Business Quant data, Shares Outstanding (Entity) for the three prior quarters was 116.27 million (Q1 2026), 115.36 million (Q4 2025) and 115.34 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Fate Therapeutics 276.57 Mn 276.57 Mn - 116.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 116.69 Mn
Mar 31, 2026 116.27 Mn
Dec 31, 2025 115.36 Mn
Sep 30, 2025 115.34 Mn
Jun 30, 2025 114.66 Mn
Mar 31, 2025 114.60 Mn
Dec 31, 2024 113.93 Mn
Sep 30, 2024 113.88 Mn
Jun 30, 2024 113.85 Mn
Mar 31, 2024 113.80 Mn
Dec 31, 2023 98.63 Mn
Sep 30, 2023 98.59 Mn
Jun 30, 2023 98.52 Mn
Mar 31, 2023 98.19 Mn
Dec 31, 2022 97.29 Mn
Sep 30, 2022 97.11 Mn
Jun 30, 2022 96.86 Mn
Mar 31, 2022 96.54 Mn
Dec 31, 2021 95.73 Mn
Sep 30, 2021 95.36 Mn
API Access

Fate Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=FATE&period=max&api_key=YOUR_API_KEY